| abstract |
A multilayer tablet comprises a first layer formulated for instant release of the angiotensin II receptor antagonist telmisartan from a dissolving tablet matrix, a second layer formulated for instant release of the angiotensin converting enzyme inhibitor ramipril and optionally a diuretic from a disintegrating tablet matrix, and, optionally, a third layer formulated for instant release of a diuretic like hydrochlorothiazide from a fast disintegrating tablet matrix. |